{
    "clinical_study": {
        "@rank": "28264", 
        "acronym": "RELIEF", 
        "arm_group": {
            "arm_group_label": "1"
        }, 
        "brief_summary": {
            "textblock": "This is  a multi-center, prospective, non-interventional study that aims to evaluate in\n      daily clinical practice the possible correlation between patient perception of the ability\n      to perform morning activities and the physician's assessment during a regular physical exam\n      in patients with Chronic Obstructive Pulmonary Disease (COPD), group C and D."
        }, 
        "brief_title": "Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease (COPD)", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "CorRELation between PatIent PErception of the Ability to Perform Morning Activities and\n      Findings on Clinical Examination in COPD Patients receiving inhaled combined therapy\n      (corticosteroid/long acting \u00df2-agonist) - RELIEF Study"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Chronic Obstructive Pulmonary Disease (COPD), group C and D according to\n             GOLD Guidelines, 2011\n\n          -  Receive inhaled combined therapy for COPD (inhaled corticosteroid / long acting\n             \u00df2-agonist); this treatment should have been initiated for at least one month before\n             entering the study\n\n          -  Current or past smokers, of at least 10 pack years\n\n        Exclusion Criteria:\n\n          -  History of exacerbation of COPD symptoms within the last month before visit 1,\n             inclusive.\n\n          -  History of asthma or allergic rhinitis.\n\n          -  History of lung carcinoma or any other respiratory condition that may limit the\n             airflow circulation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Chronic Obstructive Pulmonary Disease (COPD) patients group C and D"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703416", 
            "org_study_id": "NIS-RBG-ATC-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "GOLD group C and D", 
            "CDLM questionnaire", 
            "visual scale - physician evaluation"
        ], 
        "lastchanged_date": "April 24, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varna", 
                        "country": "Bulgaria"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Bulgaria"
        }, 
        "number_of_groups": "1", 
        "official_title": "CorRELation Between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients Receiving Inhaled Combined Therapy (Corticosteroid/Long Acting \u00df2-agonist) - RELIEF Study", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bulgaria: Bulgarian Drug Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Change from baseline in CDLM (Capacity of Daily Living during the Morning) questionnaire.", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 3 months"
            }, 
            {
                "measure": "Change from baseline of patient's general health status upon physical evaluation - visual scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 3 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703416"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Descriptive statistics will be calculated for this outcome measure", 
                "measure": "Age (years), gender (male/female), weight (kg), height (cm), place of origin (urban/rural)", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (visit 1)"
            }, 
            {
                "measure": "Number of daily walking steps (by using pedometers)", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months"
            }, 
            {
                "measure": "Patient adherence to treatment (by using visual 5 point scale)", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months"
            }, 
            {
                "measure": "Number of unscheduled visit (exacerbations, emergency visits)", 
                "safety_issue": "No", 
                "time_frame": "up to 3 months"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}